ERAS20280121C5
ERAS Jan 21 2028 5.00 Call (ERAS280121C00005000)
option OPRA

our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology's hardest problems. we have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals.